NEW YORK, NY / ACCESSWIRE / July 31, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Reckitt Benckiser Group plc (“Reckitt” or the “Company”) (OTC:RBGLY) of the September 13, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Reckitt ADSs between July 28, 2014 and April 9, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/RBGLY. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:

FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all those who purchased Reckitt American Depositary Shares (“ADSs”) between July 28, 2014 and April 9, 2019 (the “Class Period”). The case, City of Sterling Heights Police & Fire Retirement System v. Reckitt Benckiser Group plc, et al., No. 19-cv-15382 was filed on July 15, 2019.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose that Reckitt and its most senior executives perpetrated a scheme, which generated over $3 billion in proceeds, to facilitate opiate abuse among U.S. consumers and mislead investors and the public regarding the health and safety risks of Reckitt’s new key opiate product, Suboxone Film.

Prior to December 2014, the Company maintained a division dedicated to opioid addiction treatments known as Reckitt Benckiser Pharmaceuticals Inc. (“Reckitt Pharma”). For many years, Reckitt Pharma’s primary source of revenue was the manufacture and sale of Suboxone Tablets, a treatment for opioid addiction. Senior executives at Reckitt devised a plan to switch prescribers from Suboxone Tablets to the Company’s new proprietary treatment, Suboxone Film. Suboxone Film had similar active ingredients to Suboxone Tablets, however it was dispensed in a thin film placed under the tongue and stored in single-use foil wrappings. Executives planned to create a marketing campaign that touted the purported safety benefits of Suboxone Film over Suboxone Tablets in order to prevent generic competition. Key to this campaign was fabricating safety concerns with existing treatments in order to delay the entry and approval of generics for Suboxone Tablets. Between 2010 and 2014, the Company’s revenues from sales of the drug increased ten-fold to over $840 million annually.

On July 24, 2017, the Company announced, in connection with its second quarter 2017 financial results, that it had recorded a £318 million charge related to ongoing U.S. Department of Justice and U.S. Federal Trade Commission investigations into its former Reckitt Pharma operations. On this news, Reckitt’s share price fell from $21.35 per share on July 21, 2017 to a closing price of $20.34 on July 24, 2017: a $1.01 or a 4.73% drop.

On February 19, 2018, Reckitt announced, in connection with its full year 2017 financial results, that it had recorded an exceptional charge of £296 million due to the DOJ and FTC investigations, and that the California Department of Insurance was also now investigating Reckitt. On this news, Reckitt’s share price fell from $18.80 per share on February 16, 2018 to a closing price of $16.76 on February 20, 2018: a $2.04 or a 10.85% drop.

On April 9, 2019, the DOJ filed a criminal indictment against Reckitt Pharma (now Indivior), which detailed a years-long scheme to defraud the public and the Company’s investors through the marketing and sale of Suboxone Film that had generated more than $3 billion in illicit scheme proceeds. The 28- count criminal indictment charged Indivior with a multitude of felonies, including conspiracy and mail, wire and healthcare fraud, and directly implicated the top executives of Reckitt and Reckitt Pharma. On this news, Reckitt’s share price fell from $16.90 per share on April 9, 2019 to a closing price of $15.87 on April 10, 2019: a $1.03 or a 6.09% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Reckitt’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 554197

NEW YORK, NY / ACCESSWIRE / July 31, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Ascena Retail Group, Inc. (NASDAQGS:ASNA)

Lawsuit on behalf of: investors who purchased September 16, 2015 – June 8, 2017
Lead Plaintiff Deadline : August 6, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/ascena-retail-group-inc-loss-form?prid=2704&wire=1

According to the filed complaint, during the class period, Ascena Retail Group, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) the ANN Acquisition was a complete disaster for the Company as Ann’s operations were in far worse condition than had been represented to the public; (b) in order to mask the true condition of Ann, Defendants improperly delayed recognizing an impairment charge to the value of Ann’s goodwill and, as a result, Ascena’s reported income and assets were materially overstated and the Company’s financial results were not prepared in conformity with GAAP; (c) many of the brands acquired in the ANN Acquisition were in steep decline and were also materially overvalued on Ascena’s Class Period financial statements; and (d) as a result of the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company, its operations and prospects.

Anheuser-Busch Inbev Sa/Nv (NYSE:BUD)

Lawsuit on behalf of: investors who purchased March 1, 2018 – October 24, 2018
Lead Plaintiff Deadline : August 20, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/anheuser-busch-inbev-sa-nv-loss-form?prid=2704&wire=1

According to the filed complaint, Defendants issued a steady stream of materially false and misleading reassurances about Anheuser Busch’s deleveraging efforts, cost cutting measures, EBITDA growth, the sufficiency of its liquidity and its debt maturity profile during the Class Period. These positive statements by Defendants created a false impression and materially misled investors about the Company’s finances, including the sustainability of Anheuser-Busch’s dividends. Once Defendants chose to speak about Anheuser-Busch’s finances, they had a duty to speak completely and truthfully, including speaking about those factors that were then having a material adverse effect on the Company’s deleveraging efforts.

Diebold Nixdorf, Incorporated (NYSE:DBD)

Lawsuit on behalf of: investors who purchased February 14, 2017 – July 4, 2017
Lead Plaintiff Deadline : September 3, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/diebold-nixdorf-incorporated-loss-form?prid=2704&wire=1

According to the filed complaint, during the class period, Diebold Nixdorf, Incorporated made materially false and/or misleading statements and/or failed to disclose that: (1) as a result of the Wincor acquisition and related integration, the Company was less focused on its core business; (2) the Company expected certain customers would not renew their service contracts (i.e. contract runoff); (3) the Company was not adequately prepared to staff service technicians; (4) as a result of the expected contract runoff, the Company would suffer a shortage of adequately trained service technicians; (5) as a result, the Company would suffer margin pressure in its services segment; (6) as a result of the foregoing, the Company would lose market share; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 554218

NEW YORK, NY / ACCESSWIRE / July 31, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Sunlands Technology Group (“Sunlands” or the “Company”) (NYSE:STG) of the August 26, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Sunlands stock or options pursuant and or traceable to the Company’s March 23, 2018 Initial Public Offering (“IPO”) and would like to discuss your legal rights, click here: www.faruqilaw.com/STG. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017

Attn: Richard Gonnello, Esq.

rgonnello@faruqilaw.com

Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of all those who purchased Sunlands American Depository Shares (“ADS”) pursuant and or traceable to the Company’s March 23, 2018 IPO. The case, Horowitz v. Sunlands Technology Group et al., No. 19-cv-03744 was filed on June 27, 2019.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Sunlands’ student enrollment was declining; (2) Sunlands’ gross billings were declining; (3) Sunlands’ marketing tactics were not as robust as described in the Registration Statement; and (4) as a result, defendants’ statements about Sunlands’ business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On March 20, 2018, Sunlands filed its final amendment to the Registration Statement, which registered over 13 million Sunlands ADS’s for public sale, or 520,000 Class A Ordinary Shares as each ADS represented one Class A ordinary share. The SEC declared the Registration Statement effective on March 22, 2018. On March 23, 2018, Defendants priced the IPO at $11.50 per ADS and filed the final Prospectus for the IPO on Form 424B4, which forms part of the Registration Statement. Through the IPO, Defendants issued and sold approximately 13 million ADSs, pursuant to the Registration Statement.

As of the filing of the aforementioned complaint, Sunlands’ ADS price traded around $2.28 per share, representing a decline of over 80% from the Company’s IPO price.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Sunlands’ conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 554122

LOS ANGELES, CA / ACCESSWIRE / July 31, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ascena Retail Group, Inc. (“Ascena” or “the Company”) (NASDAQ:ASNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between September 16, 2015 and June 8, 2017, inclusive (the ”Class Period”), are encouraged to contact the firm before August 6, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Ascena’s acquisition of ANN, Inc. developed into a disaster for the Company based on ANN’s operations to be in far worse condition than was generally believed to be the case. The Company improperly delayed the recognition of an impairment charge related to ANN’s goodwill to mask the true extent of this problem. Based on this delay, the Company’s income and assets were overstated and its financial results were not in conformity with GAAP. Ascena overvalued many of the brands in the ANN acquisition as they were in serious decline. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Ascena, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com
Brian Schall, Esq.,
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 554215

LOS ANGELES, CA / ACCESSWIRE / July 31, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Diebold Nixdorf, Inc. (“Diebold” or “the Company”) (NYSE:DBD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between May 4, 2017 and July 4, 2017, inclusive (the ”Class Period”), are encouraged to contact the firm before September 3, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Diebold experienced delays and slowdowns in a number of areas, including system rollouts, customer decision-making, and the order-to-revenue conversion cycle. These delays had a negative impact on the Company’s operations and its service business. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Diebold, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com
Brian Schall, Esq.,
www.schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 554213

NEW YORK, NY / ACCESSWIRE / July 31, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Verb Technology Company, Inc. (“Verb” or the “Company”) (NASDAQ:VERB) of the September 9, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Verb stock or options between January 3, 2018 and May 2, 2018 and would like to discuss your legal rights, click here: www.faruqilaw.com/VERB. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all those who purchased Verb common stock between January 3, 2018 and May 2, 2018 (the “Class Period”). The case, Hartmann v. Verb Technology Company, Inc. et al., No. 19-cv-05896 was filed on July 9, 2019 and has been assigned to the Honorable George H. Wu.

On January 3, 2018, the Company announced a purported agreement with Oracle America, Inc. (herein, the “Oracle Agreement”) which received widespread attention to jointly develop Verb’s product. The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose the true scope of the Oracle Agreement as the Company did not have a contract with Oracle to jointly develop and market the Company’s product and that as a result of the foregoing, the Company’s public statements were materially false and misleading at all relevant times.

Following the rapid rise of the Company’s stock price due to the Oracle Agreement announcement, on April 23, 2018, the truth as to the Company’s relationship with Oracle began to emerge. The text of the Oracle Agreement revealed that there was no joint agreement for Oracle to use its substantial salesforce to market the Company’s product as previously touted by the Company and its CEO. Similarly, the text of the Oracle Agreement revealed that there was no joint development of the Company’s product, notifiCRM. Moreover, the text of the Oracle Agreement revealed the true nature of the relationship between Oracle and the Company: the Company had simply been provided with an application developer toolkit for its program to interface with Oracle NetSuite.

The Company and CEO Rory Cutaia had exceedingly overstated this relationship and omitted from all prior communications about the Oracle Agreement that the Company had to pay a fee to Oracle in order to participate in the partnership program and access nothing more than an application developer toolkit. The Oracle Agreement revealed that the Company had made misleading statements pertaining to Oracle’s acts upon completion of the product, despite such statements having been explicitly prohibited by the Oracle Agreement.

On April 30, 2018, Cutaia issued a video to Company shareholders assuring investors that a joint press release would be coming from Oracle “within days” though there were a number of complicating factors. No joint press release was ever issued and the market increasingly questioned the relationship between the two companies.

On this news, Verb’s share price fell from $2.70 per share on April 19, 2018 to a closing price of $1.54 on April 30, 2018: a $1.16 or a 42.96% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Verb’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 554201

NEW YORK, NY / ACCESSWIRE / July 31, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Mammoth Energy Services, Inc. (NASDAQ:TUSK)

Investors Affected : October 19, 2017 – June 5, 2019

A class action has commenced on behalf of certain shareholders in Mammoth Energy Services, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Mammoth’s subsidiary, Cobra, improperly obtained two infrastructure contracts with PREPA that totaled over $1.8 billion; (2) specifically, the contracts were awarded as the result of improper steering and not a competitive RFP process; and (3) as a result, Defendants’ statements about Mammoth’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/mammoth-energy-services-inc-loss-submission-form/?id=2703&from=1

Intelligent Systems Corporation (NYSE MKT:INS)

Investors Affected : January 23, 2019 – May 29, 2019

A class action has commenced on behalf of certain shareholders in Intelligent Systems Corporation. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Defendant Petit, the “financial expert” on the Company’s Audit Committee, engaged in accounting fraud as the CEO of MiMedx Group; (2) the Company’s CEO, Defendant Strange, engaged in undisclosed related-party transactions with Defendant Petit and others and had an undisclosed personal relationship with the Company’s auditor; (3) the Company had its employees set up or take control of shell companies in Asia so they could partake in undisclosed related-party transactions for the purpose of either fabricating revenue for the Company and/or siphoning money out of the Company; and (4) as a result, Defendants’ statements about Intelligent Systems’ business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/intelligent-systems-corporation-loss-submission-form/?id=2703&from=1

Realogy Holdings Corp. (NYSE:RLGY)

Investors Affected : February 24, 2017 – May 22, 2019

A class action has commenced on behalf of certain shareholders in Realogy Holdings Corp. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Realogy was engaged in anticompetitive behavior by requiring property sellers to pay the commissions of a buyer’s broker at an inflated rate; (2) Realogy’s anticompetitive actions would prompt the U.S. Department of Justice (“DOJ”) to open an antitrust investigation into the real estate industry’s practices regarding brokers’ commissions; and (3) as a result, Defendants’ statements about the Realogy’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/realogy-holdings-corp-loss-submission-form/?id=2703&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 554212

ALISO VIEJO, CA / ACCESSWIRE / July 31, 2019 / Many would contend that today’s fiercely competitive, high-stakes business world is no place where Christian or other religious values can thrive or have any place, to begin with. However, the history of corporate America abounds with examples of company leaders who have achieved phenomenal success without compromising on their faith and moral principles. Among them is Tony Amaradio, a financial expert whose religious devoutness has informed his decisions in both business and personal matters, establishing him as an outstanding professional, an inspirational philanthropist, and a published author whose book, Faithful with Much: Breaking Down the Barriers to Generous Giving, is now available on Amazon in Kindle, Hardcover, and Paperback formats. According to Amaradio, spirituality provides entrepreneurs with additional leverage as it guides them to operate in a manner that promotes building organizations where business success does not come at the expense of morality, ethics, and compassion.

Maltbie Babcock, a distinguished 19th-century clergyman and writer, famously said, “Business is religion, and religion is business. The man who does not make a business of his religion has a religious life of no force, and the man who does not make a religion of his business has a business life of no character.” One thing that unites all the faiths of the world is that they invariably stress the importance of honesty, integrity, family values, hard work, respect, and generosity, Tony Amaradio notes. Some of the largest companies were founded by people who applied these principles both to their private and business lives, the list including Sam Walton (retail giant Walmart), Dave Thomas (burger chain Wendy’s), and James Cash Penney (department stores operator J.C. Penny). In addition to drawing on their faith to build thriving enterprises, these leaders were celebrated for their philanthropy and created foundations which have supported countless worthy causes over the decades. In more recent times, devout high-profile executives such as Indra Nooyi (PepsiCo leader from 2001 to 2018), Donnie Smith (head of Tyson Foods, 2009-2016), Pierre Omidyar (founder of eBay), and James Tisch (CEO of Loews Corporation since 1999) have spoken about faith as an integral part of how they run their businesses. They consistently credit religion and spirituality with teaching them to be fair, truthful, generous, socially responsible, ethical, and tolerant – qualities that have shaped their professional decisions and earned them a place in the ranks of the most successful corporate leaders of modern times.

One person uniquely qualified to discuss the positive impact of faith on leadership and work practices is Reverend Scotty McLennan, who is also a lawyer, book author, public speaker, and lecturer in political economy at the Stanford Graduate School of Business. As he remarked in an interview, “Business people spend the majority of their waking hours at work, and many of them want to find it meaningful. Many also want to conduct their business affairs ethically, and most of us worldwide learn our ethics through our religious traditions or through philosophical understanding of morality that we inherit from our families, education and surrounding culture.” McLennan believes that leaders who integrate spirituality and ethical commitments into their professional lives build more successful business ventures and deliver greater satisfaction to customers and company stakeholders.

Financial expert and dedicated philanthropist Tony Amaradio is the founder and leader of Select Portfolio Management Inc and Select Money Management Inc, where he employs an innovative integrated strategy to maximize results for clients. Following the receipt of a BBA from the University of Michigan and an MBA from the University of Detroit, he commenced his career in the financial services industry, developing his talent over time to garner a stellar reputation and become recognized as a visionary and an inspirational leader. He and his wife Carin are passionate supporters of charitable causes and are often invited to speak at events hosted by non-profit organizations, many of which rely on his expertise to optimize their capacities and thus improve their effectiveness.

Anthony Amaradio – Visionary & Strategic Philanthropist: http://anthonyamaradionews.com

Tony Amaradio – Amazon.com: https://www.amazon.com/Tony-Amaradio/e/B002QK4S1O%3Fref=dbs_a_mng_rwt_scns_share

Tony Amaradio – A Life Changing Decision on Vimeo: https://vimeo.com/313895907

Tony Amaradio – YouTube: https://www.youtube.com/channel/UCPQ1zS4ut6X5y3tsQPEsKLw

Contact Information

AnthonyAmaradioNews.com
contact@anthonyamaradionews.com
www.anthonyamaradionews.com

SOURCE: Tony Amaradio

ReleaseID: 554210